GlassScriptPhysician profile
Nickolas Allen Rhoades
NPI 1821637927
$1,699.84
in general payments reported to CMS, 2019-2025
21 companies · $654 in 2025
The $654 reported for 2025 was more than what 78% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $506 · 2022: $104 · 2023: $102 · 2024: $335 · 2025: $654.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $788 · Education: $303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $787.70 |
| Education | $302.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $676.24 | 2024-2025 | Proclaim, Eterna, Octrode |
| Abbvie INC. | $255.74 | 2022-2025 | |
| Amgen INC. | $104.77 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $103.02 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $80.92 | 2021 | |
| Medtronic, INC. | $70.69 | 2022-2024 | Synchromedii, Intellis Adaptivestim, Osteocool Rf Ablation System |
| Arbor Pharmaceuticals, INC. | $53.22 | 2021 | |
| Vertos Medical, INC. | $42.24 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $38.08 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.50 | 2021 | |
| Spr Therapeutics, INC | $37.30 | 2021-2025 | Sprint Pns System |
| Boston Scientific Corporation | $36.31 | 2023-2024 | Intracept |
| Vertex Pharmaceuticals Incorporated | $35.93 | 2024-2025 | |
| Biogen, INC. | $20.74 | 2021 | |
| Radius Health, INC. | $19.22 | 2023 | Tymlos |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $18.88 | 2022 | |
| Averitas Pharma INC. | $15.46 | 2024 | Qutenza |
| Uswm, LLC | $14.88 | 2021 | |
| Si-Bone, INC. | $14.59 | 2024 | |
| Novartis Pharmaceuticals Corporation | $12.51 | 2021 | |
| Lilly USA, LLC | $11.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nickolas Rhoades listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.